With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Ozempic has FDA approval to treat type 2 diabetes. Wegovy has approval to help people lose weight when they have both obesity and weight-related health problems. Ozempic and Wegovy are part of a ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to ...

A new study shows that joining a weight loss support group such as Slimming World can quickly restore self-belief, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Justin Trudeau announced Monday that he was also stepping down as leader of Canada’s Liberal Party. He will remain in both roles until a replacement is chosen. By Matina Stevis-GridneffIan ...